1) Individuals aged between 19 and 54 years, both inclusive (for phase I) and between 19 and 80 years old, both inclusive (for phase II). 2) Physical examination without significant alterations. 3) Hematological and blood chemistry determinations within or outside normal ranges, without clinical relevance (only for phase I). 4) Voluntariness of the subject by signing the informed consent.

1) Individuals aged between 19 and 54 years, both inclusive (for phase I) and between 19 and 80 years old, both inclusive (for phase II). 2) Physical examination without significant alterations. 3) Hematological and blood chemistry determinations within or outside normal ranges, without clinical relevance (only for phase I). 4) Voluntariness of the subject by signing the informed consent.